Figure S6. from High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models
View Full Paper
Ask AI
Bookmark
Share
Abstract
Antitumor activity of CB-011 CAR-T cells in a xenograft model of multiple myeloma.
Discussion
No takes yet. Share an insight, caveat, or question.